Courtney Soulsby, Sector Development Director, Healthcare at the British Standards Institute, reveals how the industry can prepare for PFAS regulations now to get ahead of the curve. The post Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers appeared first on European Pharmaceutical Review ..read more

Colleagues from biopharmaceutical company MSD reveal what it takes to fully realise the benefits of PAT implementation. The post Beyond instruments: streamlining process technology implementation in biopharmaceutical manufacturing appeared first on European Pharmaceutical Review ..read more

Ensuring the quality, safety and efficacy of new pharmaceutical products is critical to bring them to market successfully. Here, Adragos Pharma’s Amalia Stroumpou, explains how the key to all three of these factors is rigorous good manufacturing practice (GMP) analytical testing. The post The key role of GMP analytical testing for drug products appeared first on European Pharmaceutical Review ..read more

Dave Elder reflects on the array of applications for AI to facilitate successful drug development, though proof remains elusive. The post AI in pharmaceutical development: hype or panacea? appeared first on European Pharmaceutical Review ..read more

EPR's latest Pharma Horizons report explores the latest advances in artificial intelligence (AI) for drug and clinical development, regulation and more. The post Pharma Horizons: Artificial Intelligence appeared first on European Pharmaceutical Review ..read more

Immigration law experts from Fragomen LLP discuss currently challenges in the UK’s visa system and propose recommendations for attracting science and technology talent that support the country’s competitiveness. The post The case for immigration concessions: maintaining the UK’s competitiveness in science and technology appeared first on European Pharmaceutical Review ..read more

EPR Issue 1 includes articles on manufacturing, drug delivery, process analytical technology (PAT), RNA therapeutics and more. The post <em>European Pharmaceutical Review</em> Issue 1 2025 appeared first on European Pharmaceutical Review ..read more

To mark Rare Disease Day 2025, EPR interviewed Christina Gkousgkouni, Head of Rare Diseases for Central South Europe, Sanofi. The post Preparing for a new era in the rare disease sector appeared first on European Pharmaceutical Review ..read more

Proposed US tariffs on pharmaceutical imports could disrupt global supply chains, drive up production costs, and exacerbate drug shortages. How will the industry respond? The post How could tariffs impact the pharmaceutical industry? appeared first on European Pharmaceutical Review ..read more

Here, Dr Jinpeng Li at WuXi AppTec reveals the analytical challenges that are hindering advancement of oligonucleotide therapeutics, medicines which have demonstrated clinical promise in the gene therapy space, and discusses promising analytical innovations. The post Innovating bioanalysis to advance oligonucleotide therapeutics appeared first on European Pharmaceutical Review ..read more